PharmaVoice 100
-
The 2023 PharmaVoice 100
This year’s honorees are influential and devoted leaders lifting the pillars of the industry to new heights.
By Julia Himmel • Sept. 19, 2023 -
Catching up with 2022 PharmaVoice 100 honorees
Tapping into our growing community for expertise and inspiration.
By Meagan Parrish • Sept. 13, 2023 -
PharmaVoice 100
The PharmaVoice 100 — Who makes the cut
What we’re looking for in each new class of honorees.
By Meagan Parrish • March 15, 2023 -
PharmaVoice 100 honorees: Where are they now?
How some of our past PharmaVoice 100 honorees are transforming the life sciences industry in new roles.
By Taren Grom , Karissa Waddick • March 3, 2023 -
Opinion
Healthcare tech’s biggest busts
The metaverse, blockchain, DCTs and more — here are some of the most recent fails in healthcare tech.
By Taren Grom • Dec. 2, 2022 -
10 of our most popular articles in 2022
Methadone, rock ‘n’ roll, clinical trial overhauls — here’s a look at our most-read stories of the year.
By Meagan Parrish • Nov. 30, 2022 -
Q&A
The legacy of Glen de Vries: Our last interview with the pioneering entrepreneur
Recorded just weeks before his passing, our sit-down interview with the legendary medical sciences entrepreneur showcased his passion for pushing the industry toward its next frontier.
By Taren Grom • Nov. 11, 2022 -
Opinion
What’s your leadership brand?
Pharma industry leaders share their brand personas.
By Taren Grom • Oct. 14, 2022 -
Profile // Red Jacket honorees 2022
Red Jacket: Peyton Howell
The chief operating and growth officer of Parexel has sold her market access company and created award-winning DE&I programs, but it’s her role as “connector” that she takes the greatest pride in.
By PharmaVoice staff • Sept. 15, 2022 -
Profile // Red Jacket honorees 2022
Red Jacket: Fabio Gratton
The serial entrepreneur has relied on his gift for storytelling, creativity and a bit of “magic” as he’s launched one successful niche tech company after another.
By PharmaVoice staff • Sept. 15, 2022 -
The 2022 Red Jacket honorees
Our annual PharmaVoice 100 “hall of fame” winners raise the bar on transformative leadership in life sciences.
Sept. 15, 2022 -
Profile // Red Jacket honorees 2022
Red Jacket: Udit Batra
A combination of logic and love — that’s how the CEO of Waters Corp. leads and how he inspires those around him to “solve the problems that matter.”
By PharmaVoice staff • Sept. 15, 2022 -
Profile // Red Jacket honorees 2022
Red Jacket: Jim Lang
The CEO of Eversana has made his mark on the life sciences by disrupting the status quo for commercialization — and he’s got more industry-shifting changes in the works.
By PharmaVoice staff • Sept. 15, 2022 -
Profile
Red Jacket: Quita Highsmith
The VP and chief diversity officer of Genentech is driving enterprise-wide strategies to influence how the biotech giant approaches DE&I — from clinical trials to career advancement.
By PharmaVoice staff • Sept. 15, 2022 -
Profile // PharmaVoice 100
DE&I Champions: Renata Campos
Takeda's Growth and Emerging Markets Business Unit president is driving growth by doing what’s right for patients and her teams.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
Entrepreneurs: Samantha Du
The CEO of Zai Lab is at the forefront of the movement to boost innovation in China’s biotech sector while delivering needed solutions to patients around the world.
By Meagan Parrish • Sept. 6, 2022 -
Profile // PharmaVoice 100
Entrepreneurs: Lisa Walters-Hoffert
Daré Bioscience’s CFO and co-founder is determined to rapidly advance innovations in women’s health.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
Disrupters: Jim Anthony
With a ready-for-anything attitude and a knack for relationship-building, the executive vice president and global head of Parexel Biotech is growing the CRO with a patient-first approach.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
Entrepreneurs: Armon Sharei
The CEO of SQZ Biotech is leveraging a technology platform that is simple in its design yet targeted at making cell therapy to break down barriers to the treatments.
By Michael Gibney • Sept. 6, 2022 -
Profile // PharmaVoice 100
Entrepreneurs: Dr. Penelope Manasco
How the NIH-trained scientist and CEO of MANA RBM is charting a new way forward in conducting clinical trials.
By Alexandra Pecci • Sept. 6, 2022 -
Profile // PharmaVoice 100
Tech Wizards: Dominique Demolle
How the CEO of Cognivia is revolutionizing drug development with psychonomics.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
Tech Wizards: Kunal Ghosh
The leader of Inscopix embodies a 'bootstrap' approach to entrepreneurship, from soldering early versions of the Inscopix technology to taking a 'science-first' approach to fundraising.
By Alexandra Pecci • Sept. 6, 2022 -
Profile // PharmaVoice 100
Disrupters: Trishna Bharadia
As a patient advocate, The Spark Global’s owner is transforming how pharma companies approach patient centricity.
By Alexandra Pecci • Sept. 6, 2022 -
Profile // PharmaVoice 100
Entrepreneurs: Jeff Fischer
The co-founder and president led Longhorn Vaccines and Diagnostics to an unprecedented surge in production of its testing tech at the height of COVID-19 and is now pursuing a universal flu vaccine.
By Karissa Waddick • Sept. 6, 2022 -
Profile // PharmaVoice 100
DE&I Champions: Adrelia Allen
Merck & Co.’s senior director of clinical trial patient diversity is transforming the pharma giant’s approach to inclusion and equality.
By PharmaVoice staff • Sept. 6, 2022